Krill oil

Krill oil is an OTC supplement with claimed EPA/DHA load in fewer capsules than standard fish oil. EFSA in 2010 approved an EPA+DHA claim at 250 mg/day for normal heart function – the wording is source-agnostic (fish oil, krill oil, algal omega-3). No RCT has shown a krill-oil effect on hard cardiovascular outcomes (MI, stroke, CV death). Statins and non-pharmacological measures – blood-pressure and glucose control, smoking cessation, 150 min/week activity, Mediterranean diet – have orders-of-magnitude stronger evidence (ESC 2021, SEC 2022). If krill oil was bought to replace a prescribed statin, discuss with a cardiologist; stopping a statin in confirmed coronary disease multiplies infarction risk. EPA/DHA supplementation may be considered as an add-on in severe hypertriglyceridaemia above 5 mmol/L in agreement with the treating doctor.

Krill oil is marketed as a superfood and adaptogen, promising more energy, stress resilience, and general wellness from its phospholipid-bound omega-3s. The claims lack support: no good-quality studies confirm a benefit of krill oil as a "superfood" or "adaptogen". The substance itself is harmless in this use. To correct an omega-3 deficit or support heart health, talk to your doctor about approaches with real evidence, such as a diet with oily fish and, when indicated, omega-3 products with proven effects.